Cowen downgraded Mylan (NASDAQ: MYL) from Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Mylan (MYL) Comments on Teva/Allergan Deal; Strategic Focus Remains UnchangedJuly 27, 2015 6:43 AM Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug UnitJuly 27, 2015 6:42 AM Teva Pharma (TEVA) Ends Effort to Acquire Mylan (MYL)July 27, 2015 6:07 AM Teva Withdraws Proposal to Acquire MylanJuly 27, 2015 4:31 AM